137 related articles for article (PubMed ID: 9811967)
1. Human collagen II peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis.
Diab BY; Lambert NC; L'Faqihi FE; Loubet-Lescoulié P; de Préval C; Coppin H
Immunogenetics; 1999 Jan; 49(1):36-44. PubMed ID: 9811967
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
Rosloniec EF; Whittington KB; Zaller DM; Kang AH
J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
[TBL] [Abstract][Full Text] [Related]
3. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.
Andersson EC; Hansen BE; Jacobsen H; Madsen LS; Andersen CB; Engberg J; Rothbard JB; McDevitt GS; Malmström V; Holmdahl R; Svejgaard A; Fugger L
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7574-9. PubMed ID: 9636191
[TBL] [Abstract][Full Text] [Related]
4. Properties of HLA class II molecules divergently associated with Goodpasture's disease.
Phelps RG; Jones V; Turner AN; Rees AJ
Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
Rosloniec EF; Ivey RA; Whittington KB; Kang AH; Park HW
J Immunol; 2006 Sep; 177(6):3884-92. PubMed ID: 16951351
[TBL] [Abstract][Full Text] [Related]
6. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
[TBL] [Abstract][Full Text] [Related]
7. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity versus tolerance: analysis using transgenic mice.
Taneja V; David CS
Hum Immunol; 2000 Dec; 61(12):1383-9. PubMed ID: 11163096
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.
Patil NS; Pashine A; Belmares MP; Liu W; Kaneshiro B; Rabinowitz J; McConnell H; Mellins ED
J Immunol; 2001 Dec; 167(12):7157-68. PubMed ID: 11739539
[TBL] [Abstract][Full Text] [Related]
10. HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes.
Matsushita S; Nishi T; Oiso M; Yamaoka K; Yone K; Kanai T; Nishimura Y
Int Immunol; 1996 May; 8(5):757-64. PubMed ID: 8671664
[TBL] [Abstract][Full Text] [Related]
11. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mouse models of rheumatoid arthritis.
Holmdahl R; Andersson EC; Andersen CB; Svejgaard A; Fugger L
Immunol Rev; 1999 Jun; 169():161-73. PubMed ID: 10450516
[TBL] [Abstract][Full Text] [Related]
13. T cell immunity to type II collagen in the biobreeding rat: the identification and characterization of RT1u-restricted T cell epitopes on alpha 1(II).
Cremer MA; Ye XJ; Myers LK; Brand DD; Rosloniec EF; Kang AH
J Immunol; 2004 Aug; 173(3):1795-801. PubMed ID: 15265910
[TBL] [Abstract][Full Text] [Related]
14. Human HLA-DR beta gene hypervariable region homology in the biobreeding BB rat: selection of the diabetic-resistant subline as a rheumatoid arthritis research tool to characterize the immunopathologic response to human type II collagen.
Watson WC; Thompson JP; Terato K; Cremer MA; Kang AH
J Exp Med; 1990 Nov; 172(5):1331-9. PubMed ID: 1700052
[TBL] [Abstract][Full Text] [Related]
15. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
[TBL] [Abstract][Full Text] [Related]
16. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules.
Fridkis-Hareli M; Neveu JM; Robinson RA; Lane WS; Gauthier L; Wucherpfennig KW; Sela M; Strominger JL
J Immunol; 1999 Apr; 162(8):4697-704. PubMed ID: 10202010
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
18. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition.
Zanelli E; Krco CJ; David CS
J Immunol; 1997 Apr; 158(7):3545-51. PubMed ID: 9120317
[TBL] [Abstract][Full Text] [Related]
19. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules.
Kjellén P; Brunsberg U; Broddefalk J; Hansen B; Vestberg M; Ivarsson I; Engström A; Svejgaard A; Kihlberg J; Fugger L; Holmdahl R
Eur J Immunol; 1998 Feb; 28(2):755-67. PubMed ID: 9521085
[TBL] [Abstract][Full Text] [Related]
20. Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis.
Di Sante G; Tolusso B; Fedele AL; Gremese E; Alivernini S; Nicolò C; Ria F; Ferraccioli G
EBioMedicine; 2015 Dec; 2(12):2037-45. PubMed ID: 26844284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]